The Hemofarm Pharmaceutical Co., the largest Sino-Yugoslav joint venture in China, went into production Thursday in this capital of east China's Shandong Province.
The 23-million U.S. dollars company with an annual production capacity 30 million bottles will produce a dozen varieties of transfusion medicine in plastic and glass bottles at the initial stage.
The Yugoslav side covers 70 percent of the investment in the joint venture equipped with state-of-the-art production lines imported from Germany, Italy, Sweden and Finland.
It will turn out more varieties of medicine, such as tablets, and Vitamin pills in the second-phase with an investment of US$5.2 million.
More than 400 people attended the inauguration ceremony, including Yugoslav ambassador to China Slobodan Unkovic and Yugoslavian foreign trade minister Borislav Vukovic.
The Hemofarm Pharmaceutical Co., the largest Sino-Yugoslav joint venture in China, went into production Thursday in this capital of east China's Shandong Province. The 23-million U.S. dollars company with an annual production capacity 30 million bottles will produce a dozen varieties of transfusion medicine in plastic and glass bottles at the initial stage.